- Report
- October 2024
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 143 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 179 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 188 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- July 2024
- 170 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 739 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 307 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- December 2024
- 175 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- March 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- September 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- May 2024
- 130 Pages
United States
From €5415EUR$5,950USD£4,642GBP

Alpha emitters are a type of radioactive material used in nuclear medicine and radiopharmacology. They are used to diagnose and treat diseases such as cancer, and are typically administered to patients through intravenous injections. Alpha emitters are composed of short-lived, high-energy particles that can be used to target and destroy cancer cells. They are also used in research to study the effects of radiation on cells and tissues.
The alpha emitter market is a rapidly growing sector of the nuclear medicine and radiopharmacology industry. It is driven by the increasing demand for more effective treatments for cancer and other diseases. The market is expected to continue to grow as new technologies and treatments are developed.
Some of the major companies in the alpha emitter market include Nordion, Eckert & Ziegler, and IBA Molecular. These companies specialize in the production and distribution of alpha emitters for medical and research applications. Show Less Read more